{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06107413",
            "orgStudyIdInfo": {
                "id": "M24-311"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-505110-14-00",
                    "type": "OTHER",
                    "domain": "EU CT"
                }
            ],
            "organization": {
                "fullName": "AbbVie",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab",
            "officialTitle": "A Phase 2, Randomized Study to Evaluate Safety, Efficacy, and Optimal Dose of ABBV-400 in Combination With Fluorouracil, Folinic Acid, and Bevacizumab in Previously Treated Subjects With Unresectable Metastatic Colorectal Cancer",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "study-to-assess-adverse-events-and-change-in-disease-activity-in-previously-treated-adult-participants-receiving-intravenous-iv-abbv-with-unresectable-metastatic-colorectal-cancer-in-combination-with-iv-fluorouracil-folinic-acid-and-bevacizumab"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-11-12",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-10-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-10-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-25",
            "studyFirstSubmitQcDate": "2023-10-25",
            "studyFirstPostDateStruct": {
                "date": "2023-10-30",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-27",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "AbbVie",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess adverse events and change in disease activity when ABBV-400 is given in combination with Fluorouracil, Folinic Acid, and Bevacizumab to adult participants to treat unresctable metastatic colorectal cancer.\n\nABBV-400 is an investigational drug being developed for the treatment of unresectable metastatic colorectal cancer. Fluorouracil, folinic acid, and bevacizumab is an drug approved for the treatment of unresectable metastatic colorectal cancer. Study doctors put the participants in groups called treatment arms. Each treatment arm receives a different dose of ABBV-400 in combination with fluorouracil, folinic acid, and bevacizumab (FFB) in escalating doses on two different schedules (safety lead in), followed by low or high doses of ABBV-400 in combination with FFB or fluorouracil, folinic acid, irinotecan, and bevacizumab (standard of care \\[SOC\\]) \\[dose optimization\\] on its own. Approximately 206 adult participants with unresectable metastatic colorectal cancer will be enrolled in the study in 65 sites worldwide.\n\nIn the safety lead in, participants will receive escalating intravenous (IV) ABBV-400 in combination with IV FFB on two different schedules. During the dose optimization participants will receive IV ABBV-400 in combination with FFB at low or high doses determined in the safety lead in on two different dosing schedules. The dose optimization arm will also include a comparator cohort in which participants will receive SOC. The study will run for a duration of approximately 3 years.\n\nThere may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at an approved institution (hospital or clinic). The effect of the treatment will be frequently checked by medical assessments, blood tests, questionnaires and side effects."
        },
        "conditionsModule": {
            "conditions": [
                "Unresectable Metastatic Colorectal Cancer"
            ],
            "keywords": [
                "Unresectable Metastatic Colorectal Cancer",
                "ABBV-400",
                "Fluorouracil",
                "Folinic Acid",
                "Bevacizumab",
                "Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 206,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "ABBV-400+Fluorouracil, Folinic Acid, and Bevacizumab (FFB) A",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive escalating ABBV-400 in combination with FFB on dose schedule A as part of the safety lead in, during the 3 year study duration.",
                    "interventionNames": [
                        "Drug: ABBV-400",
                        "Drug: Bevacizumab",
                        "Drug: Folinic Acid",
                        "Drug: Fluorouracil"
                    ]
                },
                {
                    "label": "ABBV-400+FFB B",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive escalating ABBV-400 in combination with FFB on dose schedule B as part of the safety lead in, during the 3 year study duration.",
                    "interventionNames": [
                        "Drug: ABBV-400",
                        "Drug: Bevacizumab",
                        "Drug: Folinic Acid",
                        "Drug: Fluorouracil"
                    ]
                },
                {
                    "label": "ABBV-400+FFB A Low",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive ABBV-400 in combination with FFB at the low dose determined in the safety lead in on dose schedule A as part of the dose optimization, during the 3 year study duration.",
                    "interventionNames": [
                        "Drug: ABBV-400",
                        "Drug: Bevacizumab",
                        "Drug: Folinic Acid",
                        "Drug: Fluorouracil"
                    ]
                },
                {
                    "label": "ABBV-400+FFB A High",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive ABBV-400 in combination with FFB at the high dose determined in the safety lead in on dose schedule A as part of the dose optimization, during the 3 year study duration.",
                    "interventionNames": [
                        "Drug: ABBV-400",
                        "Drug: Bevacizumab",
                        "Drug: Folinic Acid",
                        "Drug: Fluorouracil"
                    ]
                },
                {
                    "label": "ABBV-400+FFB B Low",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive ABBV-400 in combination with FFB at the low dose determined in the safety lead in on dose schedule B as part of the dose optimization , during the 3 year study duration.",
                    "interventionNames": [
                        "Drug: ABBV-400",
                        "Drug: Bevacizumab",
                        "Drug: Folinic Acid",
                        "Drug: Fluorouracil"
                    ]
                },
                {
                    "label": "ABBV-400+FFB B High",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive ABBV-400 in combination with FFB at the high dose determined in the safety lead in on dose schedule B as part of the dose optimization, during the 3 year study duration.",
                    "interventionNames": [
                        "Drug: ABBV-400",
                        "Drug: Bevacizumab",
                        "Drug: Folinic Acid",
                        "Drug: Fluorouracil"
                    ]
                },
                {
                    "label": "FFB+Irinotecan (Standard of Care [SOC])",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive SOC during the 3 year study duration.",
                    "interventionNames": [
                        "Drug: Bevacizumab",
                        "Drug: Folinic Acid",
                        "Drug: Fluorouracil",
                        "Drug: Irinotecan"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "ABBV-400",
                    "description": "Intravenous (IV) Infusion",
                    "armGroupLabels": [
                        "ABBV-400+FFB A High",
                        "ABBV-400+FFB A Low",
                        "ABBV-400+FFB B",
                        "ABBV-400+FFB B High",
                        "ABBV-400+FFB B Low",
                        "ABBV-400+Fluorouracil, Folinic Acid, and Bevacizumab (FFB) A"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Bevacizumab",
                    "description": "IV Infusion",
                    "armGroupLabels": [
                        "ABBV-400+FFB A High",
                        "ABBV-400+FFB A Low",
                        "ABBV-400+FFB B",
                        "ABBV-400+FFB B High",
                        "ABBV-400+FFB B Low",
                        "ABBV-400+Fluorouracil, Folinic Acid, and Bevacizumab (FFB) A",
                        "FFB+Irinotecan (Standard of Care [SOC])"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Folinic Acid",
                    "description": "IV Infusion",
                    "armGroupLabels": [
                        "ABBV-400+FFB A High",
                        "ABBV-400+FFB A Low",
                        "ABBV-400+FFB B",
                        "ABBV-400+FFB B High",
                        "ABBV-400+FFB B Low",
                        "ABBV-400+Fluorouracil, Folinic Acid, and Bevacizumab (FFB) A",
                        "FFB+Irinotecan (Standard of Care [SOC])"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Fluorouracil",
                    "description": "IV Infusion",
                    "armGroupLabels": [
                        "ABBV-400+FFB A High",
                        "ABBV-400+FFB A Low",
                        "ABBV-400+FFB B",
                        "ABBV-400+FFB B High",
                        "ABBV-400+FFB B Low",
                        "ABBV-400+Fluorouracil, Folinic Acid, and Bevacizumab (FFB) A",
                        "FFB+Irinotecan (Standard of Care [SOC])"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Irinotecan",
                    "description": "IV Infusion",
                    "armGroupLabels": [
                        "FFB+Irinotecan (Standard of Care [SOC])"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of Participants with Objective Response",
                    "description": "OR is defined as complete response (CR) and partial response (PR) as assessed by the investigator per Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1, as assessed by the investigator.",
                    "timeFrame": "Up to 24 Weeks"
                },
                {
                    "measure": "Progression Free Survival (PFS)",
                    "description": "PFS is defined as the time from the first dose of study drug to the first occurrence of radiographic progression based on RECIST version 1.1 as determined by the investigator or death from any cause, whichever occurs earlier.",
                    "timeFrame": "Up to 11 Months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Duration of Response (DOR)",
                    "description": "DOR is defined as The time from the first documented CR or PR to the first occurrence of radiographic progression per RECIST v1.1 as determined by the investigator or death from any cause, whichever occurs first.",
                    "timeFrame": "Up to 7 Months"
                },
                {
                    "measure": "Overall Survival (OS)",
                    "description": "OS is defined as the time from first dose of study drug to the event of death from any cause.",
                    "timeFrame": "Up to 3 Years"
                },
                {
                    "measure": "Percentage of Participants Achieving Best Overall Response (BOR)",
                    "description": "BOR is defined as confirmed CR or confirmed PR, or stable disease (SD) based on RECIST, version 1.1 as determined by the investigator.",
                    "timeFrame": "Up to 18 Weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of histologically or cytologically confirmed unresectable metastatic colorectal cancer (mCRC).\n* Measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1.\n\nExclusion Criteria:\n\n* Harbor the BRAF V600E mutation.\n* dMMR+/MSI-H.\n* Progressed on only one first-line (1L) systemic treatment of combination chemotherapy in the metastatic setting with or without targeted therapy.\n* Received anticancer therapy including chemotherapy, radiation therapy, immunotherapy, biologic, or any investigational therapy within 28 days or 5 half-lives of the drug (whichever is shorter) prior to the first dose of ABBV-400.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "ABBVIE CALL CENTER",
                    "role": "CONTACT",
                    "phone": "844-663-3742",
                    "email": "abbvieclinicaltrials@abbvie.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "ABBVIE INC.",
                    "affiliation": "AbbVie",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Highlands Oncology Group, PA /ID# 259424",
                    "status": "RECRUITING",
                    "city": "Springdale",
                    "state": "Arkansas",
                    "zip": "72762",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.18674,
                        "lon": -94.12881
                    }
                },
                {
                    "facility": "City of Hope National Medical Center /ID# 257576",
                    "status": "RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "Northwestern University Robert H. Lurie Comprehensive Cancer Center /ID# 260563",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611-2927",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Fort Wayne Medical Oncology and Hematology- South Office /ID# 259601",
                    "status": "RECRUITING",
                    "city": "Fort Wayne",
                    "state": "Indiana",
                    "zip": "46804",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.1306,
                        "lon": -85.12886
                    }
                },
                {
                    "facility": "Community Health Network, Inc. /ID# 257078",
                    "status": "RECRUITING",
                    "city": "Indianapolis",
                    "state": "Indiana",
                    "zip": "46250-2042",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Coordinator",
                            "role": "CONTACT",
                            "phone": "317-621-4300"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.76838,
                        "lon": -86.15804
                    }
                },
                {
                    "facility": "Duke Cancer Center /ID# 257236",
                    "status": "RECRUITING",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27710-3000",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Coordinator",
                            "role": "CONTACT",
                            "phone": "919-668-1861"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "Medical University of South Carolina /ID# 258486",
                    "status": "RECRUITING",
                    "city": "Charleston",
                    "state": "South Carolina",
                    "zip": "29425",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.77657,
                        "lon": -79.93092
                    }
                },
                {
                    "facility": "MD Anderson Cancer Center /ID# 258713",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Millennium Research and Clinical Development /ID# 257780",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77090-3063",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Coordinator",
                            "role": "CONTACT",
                            "phone": "281-440-5006"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Virginia Cancer Specialists - Fairfax /ID# 257261",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Tel Aviv Sourasky Medical Center /ID# 257090",
                    "status": "RECRUITING",
                    "city": "Tel Aviv",
                    "state": "Tel-Aviv",
                    "zip": "6423906",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.08088,
                        "lon": 34.78057
                    }
                },
                {
                    "facility": "Hadassah /ID# 257088",
                    "status": "RECRUITING",
                    "city": "Jerusalem",
                    "state": "Yerushalayim",
                    "zip": "91120",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 31.76904,
                        "lon": 35.21633
                    }
                },
                {
                    "facility": "Aichi Cancer Center Hospital /ID# 257286",
                    "status": "RECRUITING",
                    "city": "Nagoya-shi",
                    "state": "Aichi",
                    "zip": "464-8681",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.18147,
                        "lon": 136.90641
                    }
                },
                {
                    "facility": "National Cancer Center Hospital East /ID# 257282",
                    "status": "RECRUITING",
                    "city": "Kashiwa-shi",
                    "state": "Chiba",
                    "zip": "277-8577",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.86224,
                        "lon": 139.97732
                    }
                },
                {
                    "facility": "Kyoto University Hospital /ID# 257287",
                    "status": "RECRUITING",
                    "city": "Kyoto-shi",
                    "state": "Kyoto",
                    "zip": "606-8507",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.02107,
                        "lon": 135.75385
                    }
                },
                {
                    "facility": "National Cancer Center Hospital /ID# 257284",
                    "status": "RECRUITING",
                    "city": "Chuo-ku",
                    "state": "Tokyo",
                    "zip": "104-0045",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.57779,
                        "lon": 139.71685
                    }
                },
                {
                    "facility": "Seoul National University Hospital /ID# 257493",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "state": "Seoul Teugbyeolsi",
                    "zip": "03080",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Yonsei University Health System Severance Hospital /ID# 257492",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03722",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "National Taiwan University Hospital /ID# 257639",
                    "status": "RECRUITING",
                    "city": "Taipei City",
                    "state": "Taipei",
                    "zip": "100",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Taipei Veterans General Hosp /ID# 257636",
                    "status": "RECRUITING",
                    "city": "Taipei",
                    "zip": "11217",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Related Info",
                    "url": "https://www.abbvieclinicaltrials.com/study/?id=M24-311"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "AbbVie is committed to responsible data sharing regarding the clinical trials we sponsor. This includes access to anonymized, individual and trial-level data (analysis data sets), as well as other information (e.g., protocols, analyses plans, clinical study reports), as long as the trials are not part of an ongoing or planned regulatory submission. This includes requests for clinical trial data for unlicensed products and indications.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "CSR"
            ],
            "timeFrame": "For details on when studies are available for sharing visit https://vivli.org/ourmember/abbvie/",
            "accessCriteria": "Access to this clinical trial data can be requested by any qualified researchers who engage in rigorous independent scientific research, and will be provided following review and approval of a research proposal and statistical analysis plan and execution of a data sharing statement. Data requests can be submitted at any time after approval in the US and/or EU and a primary manuscript is accepted for publication. For more information on the process, or to submit a request, visit the following link https://www.abbvieclinicaltrials.com/hcp/data-sharing/",
            "url": "https://vivli.org/ourmember/abbvie/"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000015179",
                    "term": "Colorectal Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007414",
                    "term": "Intestinal Neoplasms"
                },
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000003108",
                    "term": "Colonic Diseases"
                },
                {
                    "id": "D000007410",
                    "term": "Intestinal Diseases"
                },
                {
                    "id": "D000012002",
                    "term": "Rectal Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M17890",
                    "name": "Colorectal Neoplasms",
                    "asFound": "Colorectal Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10448",
                    "name": "Intestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6336",
                    "name": "Colonic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10444",
                    "name": "Intestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14844",
                    "name": "Rectal Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002955",
                    "term": "Leucovorin"
                },
                {
                    "id": "D000005492",
                    "term": "Folic Acid"
                },
                {
                    "id": "D000068258",
                    "term": "Bevacizumab"
                },
                {
                    "id": "D000005472",
                    "term": "Fluorouracil"
                },
                {
                    "id": "D000077146",
                    "term": "Irinotecan"
                },
                {
                    "id": "D000058766",
                    "term": "Levoleucovorin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000020533",
                    "term": "Angiogenesis Inhibitors"
                },
                {
                    "id": "D000043924",
                    "term": "Angiogenesis Modulating Agents"
                },
                {
                    "id": "D000006133",
                    "term": "Growth Substances"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000006131",
                    "term": "Growth Inhibitors"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000964",
                    "term": "Antimetabolites, Antineoplastic"
                },
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000059004",
                    "term": "Topoisomerase I Inhibitors"
                },
                {
                    "id": "D000059003",
                    "term": "Topoisomerase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000000931",
                    "term": "Antidotes"
                },
                {
                    "id": "D000020011",
                    "term": "Protective Agents"
                },
                {
                    "id": "D000014803",
                    "term": "Vitamin B Complex"
                },
                {
                    "id": "D000014815",
                    "term": "Vitamins"
                },
                {
                    "id": "D000018977",
                    "term": "Micronutrients"
                },
                {
                    "id": "D000006397",
                    "term": "Hematinics"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M1671",
                    "name": "Irinotecan",
                    "asFound": "Related",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8600",
                    "name": "Fluorouracil",
                    "asFound": "According",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8618",
                    "name": "Folic Acid",
                    "asFound": "Web-",
                    "relevance": "HIGH"
                },
                {
                    "id": "M246",
                    "name": "Bevacizumab",
                    "asFound": "Non-",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6191",
                    "name": "Leucovorin",
                    "asFound": "Web-",
                    "relevance": "HIGH"
                },
                {
                    "id": "M29233",
                    "name": "Levoleucovorin",
                    "asFound": "Web-",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17546",
                    "name": "Vitamin B Complex",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M22318",
                    "name": "Angiogenesis Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M9231",
                    "name": "Growth Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M29349",
                    "name": "Topoisomerase I Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M29348",
                    "name": "Topoisomerase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4250",
                    "name": "Antidotes",
                    "relevance": "LOW"
                },
                {
                    "id": "M21869",
                    "name": "Protective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M17558",
                    "name": "Vitamins",
                    "relevance": "LOW"
                },
                {
                    "id": "M21009",
                    "name": "Micronutrients",
                    "relevance": "LOW"
                },
                {
                    "id": "M16885",
                    "name": "Trace Elements",
                    "relevance": "LOW"
                },
                {
                    "id": "M9485",
                    "name": "Hematinics",
                    "relevance": "LOW"
                },
                {
                    "id": "T446",
                    "name": "Folic Acid",
                    "asFound": "Web-",
                    "relevance": "HIGH"
                },
                {
                    "id": "T447",
                    "name": "Folinic Acid",
                    "asFound": "Web-",
                    "relevance": "HIGH"
                },
                {
                    "id": "T448",
                    "name": "Folate",
                    "asFound": "Web-",
                    "relevance": "HIGH"
                },
                {
                    "id": "T475",
                    "name": "Vitamin B9",
                    "asFound": "Web-",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                },
                {
                    "abbrev": "Vi",
                    "name": "Vitamins"
                }
            ]
        }
    },
    "hasResults": false
}